May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Sohini Das Mumbai
Adar Poonawalla, CEO of Serum Institute of India Ltd

Adar Poonawalla, CEO of Serum Institute of India Ltd. (Photo: Bloomberg)

The world’s largest vaccine maker Serum Institute of India (SII) which is making the AstraZeneca and Novavax vaccines for Covid-19 in India said that it may start supplies to the global Covid vaccine alliance Covax by the end of this year. In a statement the firm also noted that it continues to prioritise India and has never exported Covid vaccines at the ‘cost of the people in India’.
In a message posted on micro-blogging site Twitter, SII said that it has delivered more than 200 million doses, even though it received EUA two months after the US pharma companies. “If we look at total doses produced and delivered, we rank among the top three in the world. We continue to scale up manufacturing and prioritise India,” the statement by SII CEO Adar Poonawalla said.
Poonawalla said that they hoped to start delivering to Covax and other countries by the end of this year. “We would like to reiterate that we have nev

Also Read

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

Exports of Covid-19 vaccines may start in 2 weeks: SII CEO Adar Poonawalla

Raw material shortage may affect scaling up of Covishield production

Adar Poonawalla to acquire 60% in Magma Fincorp for Rs 3,456-crore

Covishield stock for 18-44 running out; may have to stop vaccination: AAP

Top headlines: TaMo sees surprise Q4 loss; Canara Bank posts profit in Q4

Covid: Covaxin trials for kids to start in next 10-12 days, says Paul

Uttar Pradesh reports 8,737 new coronavirus cases, 255 deaths on May 18

Lockdown in Odisha extended till June 1 to tackle coronavirus infections

First Published: May 18 2021 | 8:13 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to